DDO anticorps (C-Term)
-
- Antigène Voir toutes DDO Anticorps
- DDO (D-Aspartate Oxidase (DDO))
-
Épitope
- C-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp DDO est non-conjugé
-
Application
- Western Blotting (WB)
- Purification
- Purified
- Immunogène
- DDO antibody was raised in rabbit using the C terminal of DDO as the immunogen
- Top Product
- Discover our top product DDO Anticorps primaire
-
-
- Indications d'application
- Optimal conditions should be determined by the investigator.
- Commentaires
-
DDO Blocking Peptide, catalog no. 33R-7846, is also available for use as a blocking control in assays to test for specificity of this DDO antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Antigène
- DDO (D-Aspartate Oxidase (DDO))
- Autre désignation
- DDO (DDO Produits)
- Sujet
- The protein encoded by this gene is a peroxisomal flavoprotein that catalyzes the oxidative deamination of D-aspartate and N-methyl D-aspartate. Flavin adenine dinucleotide or 6-hydroxyflavin adenine dinucleotide can serve as the cofactor in this reaction. Two transcript variants encoding different isoforms have been found for this gene. Synonyms: Polyclonal DDO antibody, Anti-DDO antibody, D-aspartate oxidase antibody, DASOX antibody, DDO-1 antibody, DDO-2 antibody, FLJ45203 antibody.
-